Zdrowie i gospodarka · 10/06/2015
FDA Releases Draft Guidance for Duchenne Muscular Dystrophy Treatment Drugs
The FDA is releasing a draft guidance to help pharmaceutical companies develop drugs for treating X-linked Duchenne muscular dystrophy and related conditions